1 / 8

Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs. Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370.

nasim-alvarez
Download Presentation

Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  2. Kaplan-Meier analysis of time to death in patients prescribed celecoxib, rofecoxib,or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  3. Baseline characteristics of patients with congestive heart failure prescribed celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  4. Prescribing characteristics for patients given celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  5. Kaplan-Meier analysis of time to recurrent congestive heart failure in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  6. Unadjusted rates of study events in patients with congestive heart failure who were prescribed celecoxib,rofecoxib,or non-steroidal anti-inflammatory drugs (NSAIDs) Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  7. Adjusted hazard ratios (95%confidence intervals) for death and recurrent congestive heart failure,combined and alone, according to exposure group Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

  8. Marie Hudson,Hugues Richard,Louise Pilote BMJ 2005;330:1370

More Related